Radiation therapy reduces local failure and improves overall survival in sPNET

Pediatric Blood and Cancer

Volumn 51, Issue 1, 2008, Pages 148-

  Spalding, Aaron C ^a,b   Hamstra, Daniel A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CHILD; HUMAN; LETTER; MINIMAL RESIDUAL DISEASE; MORBIDITY; NEUROECTODERM TUMOR; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE; RADIOTHERAPY; SURVIVAL RATE; TREATMENT FAILURE;

EID: 44149115474     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21513     Document Type: Letter

References (9)

1. Fangusaro J, Finlay J, Sposto R, et al. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience. Pediatr Blood Cancer 2007;50:312-318.
2. Timmermann B, Kortmann RD, Kuhl J, et al. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: Results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 2006;24:1554-1560.
3. Johnston DL, Keene DL, Lafay-Cousin L, et al. Supratentorial primitive neuroectodermal tumors: A Canadian pediatric brain tumor consortium report. J Neurooncol 2008;86:101-109.
4. Hong TS, Mehta MP, Boyett JM, et al. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study. Int J Radiat Oncol Biol Phys 2004;60:204-213.
5. Grill J, Sainte-Rose C, Jouvet A, et al. Treatment of medulloblastoma with postoperative chemotherapy alone: An SFOP prospective trial in young children. Lancet Oncol 2005;6:573-580.
6. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-986.
7. Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004;22:3156-3162.
8. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004;5:399-408.
9. Carrie C, Muracciole X, Gomez F, et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 2005;63:711-716.